Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
549,770
-
Share change
-
-172,538
-
Total reported value
-
$2,468,000
-
Price per share
-
$4.49
-
Number of holders
-
16
-
Value change
-
-$816,860
-
Number of buys
-
5
-
Number of sells
-
7
Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS (GLMD) as of Q2 2016
As of 30 Jun 2016,
GALMED PHARMACEUTICALS LTD - SHS (GLMD) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
549,770 shares.
The largest 10 holders included
Park West Asset Management LLC, 683 Capital Management, LLC, Knoll Capital Management, LP, GRT CAPITAL PARTNERS L.L.C., DRILL CRAIG A, MENTA CAPITAL LLC, CapWealth Advisors, LLC, RENAISSANCE TECHNOLOGIES LLC, Williams Jones & Associates LLC, and DEUTSCHE BANK AG\.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.